Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Tejas Karwadia"'
Publikováno v:
World Journal of Oncology
The utility of immunotherapy, such as pembrolizumab, is becoming essential in the treatment of certain cancers. Pembrolizumab works through binding of programmed cell death 1 receptor that blocks the binding of the programmed cell death ligand 1 and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9724bb4eb6e97f4476cd90ee4aa9d631
https://doi.org/10.14740/wjon1085w
https://doi.org/10.14740/wjon1085w
